Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients

被引：0
|
作者：
Dong Woo Shin
Minseok Albert Kim
Jong-chan Lee
Jaihwan Kim
Jin-Hyeok Hwang
机构：
[1] Seoul National University College of Medicine,Department of Internal Medicine
[2] Seoul National University Bundang Hospital,Division of Gastroenterology, Department of Internal Medicine
[3] Keimyung University School of Medicine,Department of Internal Medicine
[4] Keimyung University Dongsan Medical Center,undefined
[5] Seoul National University College of Medicine,undefined
[6] Seoul National University Hospital,undefined
来源：
BMC Research Notes | / 14卷
关键词：
Locally advanced pancreatic cancer; Skeletal muscle; Adipose tissue; Prognosis; FOLFIRINOX;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma
    Ulaner, GA
    Huang, HY
    Otero, J
    Zhao, ZQ
    Ben-Porat, L
    Satagopan, JM
    Gorlick, R
    Meyers, P
    Healey, JH
    Huvos, AG
    Hoffman, AR
    Ladanyi, M
    CANCER RESEARCH, 2003, 63 (08) : 1759 - 1763
  • [22] Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer
    Min, Ji Hye
    Yu, Jeong Il
    Kim, Seong Hyun
    Kim, Young Kon
    Kim, Kangpyo
    Park, Hee Chul
    Park, Joon Oh
    Hong, Jung Yong
    Lee, Kyu Taek
    Lee, Kwang Hyuck
    Lee, Jong Kyun
    Park, Joo Kyung
    Choi, Jin Ho
    Heo, Jin Seok
    Han, In Woong
    Kim, Hongbeom
    Shin, Sang Hyun
    Yoon, So Jung
    Woo, Sook-young
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (01)
  • [23] Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
    Suzuki, Yukari
    Saito, Kei
    Nakai, Yousuke
    Oyama, Hiroki
    Kanai, Sachiko
    Suzuki, Tatsunori
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Saito, Tomotaka
    Hamada, Tsuyoshi
    Takahara, Naminatsu
    Tateishi, Ryosuke
    Fujishiro, Mitsuhiro
    SUPPORTIVE CARE IN CANCER, 2023, 31 (03)
  • [24] Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX
    Kaga, Yasuhiro
    Sunakawa, Yu
    Kubota, Yutaro
    Tagawa, Teppei
    Yamamoto, Taikan
    Ikusue, Toshikazu
    Uto, Yu
    Miyashita, Kouichirou
    Toshima, Hirokazu
    Kobayashi, Kouji
    Hisamatsu, Atsushi
    Ichikawa, Wataru
    Sekikawa, Takashi
    Shimada, Ken
    Sasaki, Yasutsuna
    ONCOTARGET, 2016, 7 (41) : 67314 - 67320
  • [25] Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
    Yukari Suzuki
    Kei Saito
    Yousuke Nakai
    Hiroki Oyama
    Sachiko Kanai
    Tatsunori Suzuki
    Tatsuya Sato
    Ryunosuke Hakuta
    Kazunaga Ishigaki
    Tomotaka Saito
    Tsuyoshi Hamada
    Naminatsu Takahara
    Ryosuke Tateishi
    Mitsuhiro Fujishiro
    Supportive Care in Cancer, 2023, 31
  • [26] Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancers
    Nasu, Nanami
    Yasui-Yamada, Sonoko
    Kagiya, Natsumi
    Takimoto, Mami
    Kurokawa, Yumiko
    Tani-Suzuki, Yoshiko
    Kashihara, Hideya
    Saito, Yu
    Nishi, Masaaki
    Shimada, Mitsuo
    Hamada, Yasuhiro
    NUTRITION, 2022, 103-104
  • [27] Characterization of a loss of skeletal muscle mass in advanced pancreatic cancer patients receiving chemotherapy
    Tatematsu, Noriatsu
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
    Basile, Debora
    Parnofiello, Annamaria
    Vitale, Maria Grazia
    Cortiula, Francesco
    Gerratana, Lorenzo
    Fanotto, Valentina
    Lisanti, Camilla
    Pelizzari, Giacomo
    Ongaro, Elena
    Bartoletti, Michele
    Garattini, Silvio Ken
    Andreotti, Victoria Josephine
    Bacco, Anna
    Iacono, Donatella
    Bonotto, Marta
    Casagrande, Mariaelena
    Ermacora, Paola
    Puglisi, Fabio
    Pella, Nicoletta
    Fasola, Gianpiero
    Aprile, Giuseppe
    Cardellino, Giovanni G.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2019, 10 (02) : 368 - 377
  • [29] PROGNOSTIC SIGNIFICANCE OF SKELETAL MUSCLE MASS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS
    Namisaki, Tadashi
    Sato, Shinya
    Kaji, Kosuke
    Nishimura, Norihisa
    Yoshiji, Hitoshi
    HEPATOLOGY, 2024, 80 : S1110 - S1110
  • [30] Neoadjuvant FOLFIRINOX in patients with resectable pancreatic cancer
    Shahda, Safi
    House, Michael G.
    Schmidt, C. Max
    Nakeeb, Attila
    Sehdev, Amikar
    Lin, Jingmei
    Cramer, Harvey M.
    Tong, Yan
    Flynn, Janet R.
    Zyromski, Nicholas J.
    O'Neil, Bert H.
    CANCER RESEARCH, 2016, 76
12345